Concepedia

Polly Pine

PP

19

Publications

2.6K

Citations

17

H-Index

1987

Active since

Affiliations

Rigel (United States)(Current)

Sunesis (United States)

National Jewish Health

Beth Israel Deaconess Medical Center

University of Colorado Denver

Polly Pine is an author at Rigel (United States) specializing in medicine, immunology, and cell signaling.

Top concepts

Publications per year

1987–2013

19

Publications

19

R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer

Sacha J. Holland, Alison Pan, Christian Franci et al. · Cancer Research · 2010 · 542 citations · Full text

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 508 citations

Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor

Polly Pine, Betty Chang, Nathan Schoettler et al. · Clinical Immunology · 2007 · 206 citations

, , +12

An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

Frances Rena Bahjat, Polly Pine, Andrea Reitsma et al. · Arthritis & Rheumatism · 2008 · 172 citations

Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus‐prone mice

Guo‐Min Deng, Lena Liu, Frances Rena Bahjat et al. · Arthritis & Rheumatism · 2010 · 170 citations · Full text

Rows per page

1–5 of 19